NCF2 p.Arg102Gln
c.305G>A · rs137854515 · VCV1020940
Computational evidence
| Protein change | ||
| AlphaMissense | 0.8017 | likely pathogenic |
|---|---|---|
| REVEL | 0.661 | pathogenic-leaning |
| SaProt | LLR -11.24 | damaging |
| ⇒ AlphaMissense, REVEL and SaProt all call this damaging. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 7.6 | GERP 2.1, phastCons 1 |
| Regional constraint | o/e 0.83 | unconstrained · MANE · 34 kb · p 1.3e-05 · regional, not allelic |
| Overall | ||
| CADD | 26.4 | PHRED · no single calibrated threshold — expert panels disagree |
ClinVar classifies this uncertain; the computational predictors unanimously lean damaging — a triage signal, not a reclassification
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| East Asiangrpmax | 0.0134% | 7,482 |
| Admixed American | 0.00333% | 29,998 |
| South Asian | 0.00329% | 30,359 |
| European (non-Finnish) | 0.000678% | 147,496 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- NCF2
- Protein
- p.Arg102Gln
- Coding
- c.305G>A
- MANE Select
- NM_000433
- dbSNP
- rs137854515
- Type
- single nucleotide variant
- Location
- chr1:183577660 (GRCh38)
- Gene constraint
- LOEUF 0.799 · pLI <0.01 · ClinGen HI gene assoc. with recessive phenotype (gnomAD)
- Structure
- AlphaFold pLDDT 78.99 · 7 PDB
- Residue 102
- a UniProt-annotated variant site (in cgd2); a turn
Disease context
granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 2 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor Chronic granulomatous disease (Orphanet):
- Inheritance
- Autosomal recessive, X-linked recessive
- Onset
- Adolescent, Adult, Childhood, Infancy
- Prevalence
- 1-9 / 1 000 000 (Worldwide)
Similar variants
- NCF2 p.Arg102Ter Pathogenic ★★ same residue
- NCF2 c.257+1G>A Pathogenic/Likely pathogenic ★★ same condition
- NCF2 c.366+1G>A Pathogenic ★★ same condition
- NCF2 c.714-2A>G Likely pathogenic ★★ same condition
- NCF2 p.Ala202Val Pathogenic/Likely pathogenic ★★ same condition
- NCF2 p.Arg184Ter Pathogenic/Likely pathogenic ★★ same condition
- NCF2 p.Arg66Ter Pathogenic ★★ same condition
- NCF2 p.Arg77Ter Pathogenic ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/ncf2-p-arg102gln (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown